Page 10 - கேத்தரின் ஸ்கஸ்டர் காயங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கேத்தரின் ஸ்கஸ்டர் காயங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கேத்தரின் ஸ்கஸ்டர் காயங்கள் Today - Breaking & Trending Today

Why infectious coronavirus variant worse than deadly variant: Expert

Thomas Lohnes/Getty Images
The novel coronavirus responsible for the pandemic has mutated. One variant, called B.1.1.7, is more infectious and has forced the UK into lockdown.
The variant has also been discovered in multiple US states and in other countries.
The variant does not appear to be more deadly, and experts believe existing vaccines should work against it.
But Adam Kucharski, an assistant professor at the London School of Hygiene & Tropical Medicine, said that, in general, a variant that s 50% more transmissible is a bigger problem than a variant that s 50% more deadly.
A really severe disease that one person gets won t necessarily have as much impact as a sometimes-severe disease that a huge number of people get, he told Business Insider. ....

United Kingdom , Adam Kucharski Adamjkucharski , Adam Kucharski , Catherine Schuster Bruce , London School For Hygiene , London School Of Hygiene , Public Health England , London School , Tropical Medicine , Business Insider , ஒன்றுபட்டது கிஂக்டம் , கேத்தரின் ஸ்கஸ்டர் காயங்கள் , லண்டன் பள்ளி க்கு சுகாதாரம் , லண்டன் பள்ளி ஆஃப் சுகாதாரம் , பொது ஆரோக்கியம் இங்கிலாந்து , லண்டன் பள்ளி , வெப்பமண்டல மருந்து , வணிக உள் ,

A top scientist explains why a more infectious coronavirus variant is a bigger problem than a deadlier strain

»
A top scientist explains why a more infectious coronavirus variant is a bigger problem than a deadlier strain
A top scientist explains why a more infectious coronavirus variant is a bigger problem than a deadlier strain
Dr. Catherine Schuster-BruceJan 6, 2021, 23:23 IST
A nurse puts on her Personal Protective Equipment before tending to a COVID-19 patient on October 21, 2020 in Essen, Germany.Thomas Lohnes/Getty Images
The deadly coronavirus that s spread across the world has mutated. One variant, called B.1.1.7, is more infectious, and has forced the UK into national lockdown.
The variant has also been discovered in multiple US states, and in other countries around the world. ....

United Kingdom , United States , Lisa Taylor , Adam Kucharski Adamjkucharski , Joe Raedle Getty , Adam Kucharski , Catherine Schuster Bruce , Research Centers Of America On , London School For Hygiene , London School Of Hygiene , Public Health England , London School , Tropical Medicine , Business Insider , Model Lisa Taylor , Research Centers , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , லிசா டெய்லர் , கேத்தரின் ஸ்கஸ்டர் காயங்கள் , ஆராய்ச்சி மையங்கள் ஆஃப் அமெரிக்கா ஆன் , லண்டன் பள்ளி க்கு சுகாதாரம் , லண்டன் பள்ளி ஆஃப் சுகாதாரம் , பொது ஆரோக்கியம் இங்கிலாந்து , லண்டன் பள்ளி , வெப்பமண்டல மருந்து ,

Slaoui: COVID variant 'should be under control' with vaccine

AP Photo/Evan Vucci
Moncef Slaoui, head of the White House s Operation Warpspeed, said the new coronavirus variant should be under control with the vaccines.
This virus actually mutates as part of its normal behavior, and therefore it is normal to expect there will be variants, Slaoui said in an interview on CBS Face the Nation on Sunday.
Vaccine companies and health experts have said that the coronavirus vaccines, should work to protect against the new variant that is believed to be up to to 70% more transmissible.
Moncef Slaoui, head of the White House s Operation Warpspeed, said the new coronavirus variant should be under control with the vaccines. ....

United States , San Diego , United Kingdom , Moncef Slaoui , Catherine Schuster Bruce , White House , Operation Warp Speed , Face The Nation , Business Insider , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , ஒன்றுபட்டது கிஂக்டம் , கேத்தரின் ஸ்கஸ்டர் காயங்கள் , வெள்ளை வீடு , செயல்பாடு போரிடு வேகம் , முகம் தி தேசம் , வணிக உள் ,

Healthcare startups poised to take off, according to top VCs

This story is available exclusively to Insider subscribers.
Become an Insider and start reading now.
Healthcare startups that had a breakout year in 2020 are poised to have an even better 2021, investors told Business Insider.
Startups, especially those focused on virtual care benefitted from being in the right place at the right time amid the global pandemic.
Business Insider interviewed dozens of venture capitalists and other private investors to learn which startups are poised to take off in 2021.
Looking back, 2020 will likely mark a sea change for healthcare startups.
Many startups saw a pandemic-sized opportunity and took advantage of new technology and newly agile hospitals and clinics to break into the notoriously difficult field. ....

United States , United Kingdom , San Diego , City Of , Ursheet Parikh , Andrew Dunn , Kleiner Perkins , Mayfield Ursheet Parikh , Sumi Das , Alex Morgan , Zavain Dar , Sarah Guo , Michael Yang , Pierre Socha , Peter Foley , Jessica Zeaske , Catherine Schuster Bruce , Paul Mischel , Emily Melton , Kristin Baker Spohn , Shelby Livingston , Racquel Bracken , Tim Guilliams , Robert Nelsen , Suranga Chandratillake , Capitalg Sumi Das ,

BioNTech's CEO said there's a 'relatively high' possibility the vaccine they made with Pfizer will protect against the UK's new coronavirus variant

BioNTech s CEO said there s a relatively high possibility the vaccine they made with Pfizer will protect against the UK s new coronavirus variant
ichoi@businessinsider.com (Inyoung Choi)
© Provided by Business Insider
An Ohio State employee receives a Pfizer-BioNTech COVID-19 vaccination. AP Photo/Jay LaPrete
BioNTech CEO Ugur Sahin, whose company is Pfizer s vaccine partner in Europe, told reporters on Tuesday that the likelihood their shot would work with regards to the UK variant was relatively high, the Associated Press reported.
Sahin noted that we don t know at the moment if our vaccine is also able to provide protection against this new variant, and it will take up to two weeks to get data from the experiment to learn about the vaccine s efficacy. ....

City Of , United Kingdom , United States , Scott Gottlieb , Anthony Fauci , Jay Laprete , Joshua Zitser , Catherine Schuster Bruce , Ugur Sahin , Drug Administration , Associated Press , University Of Bristol , Business Insider An Ohio State , Business Insider , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , ஸ்காட் காட்‌லீப் , கேத்தரின் ஸ்கஸ்டர் காயங்கள் , தொடர்புடையது ப்ரெஸ் , பல்கலைக்கழகம் ஆஃப் பிரிஸ்டல் , வணிக உள் ஒரு ஓஹியோ நிலை , வணிக உள் ,